| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Fennec Pharmaceuticals Inc. ("Issuer")
13G/A
FENC · 31447P100
|
4.5% |
11/16/2026
Event 9/30/2026
|
||||
| Sonic Fund II, L.P. | 4.1% | |||||
| Sonic GP LLC | 4.1% | |||||
| Lawrence Kam | 4.5% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.